+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Adhesive capsulitis of the shoulder, treatment with corticosteroid, corticosteroid with distension or treatment-as-usual; a randomised controlled trial in primary care

Adhesive capsulitis of the shoulder, treatment with corticosteroid, corticosteroid with distension or treatment-as-usual; a randomised controlled trial in primary care

Bmc Musculoskeletal Disorders 17: 232

Optimal management for adhesive shoulder capsulitis (frozen shoulder) is currently unclear. We intended to explore whether treatment by intra-articular injections with corticosteroid and distension is more effective than treating with corticosteroids alone or treatment-as-usual in a primary care setting in Norway. In this prospective randomised intention to treat parallel study, 106 patients were block randomised to three groups; 36 (analysed 35) receiving steroid injection and Lidocaine (IS), 34 receiving steroid and additional saline as distension (ISD) and 36 had treatment-as-usual (TAU). Intervention groups received four injections within 8 weeks, assessed on 1st visit, at the 4th and 8th week. Outcomes were Shoulder Pain and Disability Index (SPADI), Numerical pain rating scale (NPRS) and passive range of motion (PROM). Postal assessment was repeated after 1 year for SPADI. Patients in the IS and ISD groups were "blinded" for intervention received and the assessor was "blinded" to group allocation. At baseline there were no differences between groups in outcome measures. There were no statistical significant differences between the intervention groups in SPADI, NPRS and PROM at baseline, at short-term (4-and 8 weeks) or long-term (12 months). There were statistically significant differences (p < 0.01) in change scores at short-term for SPADI when comparing the IS and TAU groups (-20.8; CI-28.9 to -12.7), and the ISD and TAU groups (-21.7; CI-29.4 to -14.0), respectively for NPRS (-2.0; CI-2.8 to -1.1 and -2.2; CI-3.0 to -1.4), and for PROM, but not at long-term for SPADI (p > 0.05). Effect size (ES) at 8 weeks was large between both injection groups and TAU (ES 1.2). At 12 months ES was reduced to 0.3 and 0.4 respectively. Transitory side effects as flushing and after-pain were reported by 14 % in intervention groups. This intention to treat RCT in primary care indicates that four injections with corticosteroid with or without distension, given with increasing intervals during 8 weeks, were better than treatment-as-usual in treatment of adhesive shoulder capsulitis. However, in the long run no difference was found between any of the groups, indicating that natural healing takes place independent of treatment or not. ClinicalTrials.gov, https://clinicaltrials.gov/ identifier: NCT01570985.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 057140149

Download citation: RISBibTeXText

PMID: 27229470

DOI: 10.1186/s12891-016-1081-0

Related references

Capsule-Preserving Hydrodilatation With Corticosteroid Versus Corticosteroid Injection Alone in Refractory Adhesive Capsulitis of Shoulder: A Randomized Controlled Trial. Archives of Physical Medicine and Rehabilitation 98(5): 815-821, 2016

A pragmatic randomised controlled trial of local corticosteroid injection and physiotherapy for the treatment of new episodes of unilateral shoulder pain in primary care. Annals of the Rheumatic Diseases 62(5): 394-399, 2003

The Effects and Costs of Physiotherapy and Corticosteroid Injections for Capsulitis of the Shoulder: Design of a randomised clinical trial in primary care. PhysioTherapy 82(7): 411-0, 1996

Effect of arthrographic shoulder joint distension with saline and corticosteroid for adhesive capsulitis. British Journal of Sports Medicine 38(4): 384-385, 2004

Corticosteroid injection for adhesive capsulitis in primary care: a systematic review of randomised clinical trials. Singapore Medical Journal 57(12): 646-657, 2016

Efficacies of corticosteroid injection at different sites of the shoulder for the treatment of adhesive capsulitis. Journal of Shoulder and Elbow Surgery 22(4): 521-527, 2013

Effectiveness of corticosteroid injections versus physiotherapy for treatment of painful stiff shoulder in primary care: randomised trial. Bmj 317(7168): 1292-1296, 1998

Intra-articular corticosteroid injection for the treatment of idiopathic adhesive capsulitis of the shoulder. Hss Journal 3(2): 202-207, 2008

Shoulder adhesive capsulitis: systematic review of randomised trials using multiple corticosteroid injections. British Journal of General Practice 57(541): 662-667, 2007

Pragmatic randomised controlled trial of local corticosteroid injection and naproxen for treatment of lateral epicondylitis of elbow in primary care. Bmj 319(7215): 964-968, 1999

A prospective randomized trial comparing manipulation under anaesthesia and capsular distension for the treatment of adhesive capsulitis of the shoulder. Shoulder & Elbow 4(2): 95-99, 2012

Single intra-articular platelet-rich plasma versus corticosteroid injections in the treatment of adhesive capsulitis of the shoulder: a cohort study. American Journal of Physical Medicine & Rehabilitation 2019, 2019

The contribution of capsular distension to the treatment of primary adhesive capsulitis of the shoulder: a comparative study versus rehabilitation. Annales de Readaptation et de Medecine Physique 51(9): 722-728, 2009

High- vs Low-Dose Corticosteroid Injection in the Treatment of Adhesive Capsulitis with Severe Pain: A Randomized Controlled Double-Blind Study. Pain Medicine 19(4): 735-741, 2017

Intra-articular corticosteroid injection in diabetic patients with adhesive capsulitis: a randomized controlled trial. Knee Surgery, Sports Traumatology, Arthroscopy 20(10): 1947-1952, 2013